Mendus AB (publ)

kr 5.36As of Sun 8 Nov 2026, 12:00 UTC
STO:IMMUHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (35.51%)
Div yield —
ROE (17.94%)
Biotechnology
Beta (5Y) 1.01
PE TTM —
TSR TTM (28.25%)
Mkt cap kr 343.7M
ROIC (10.45%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 5.42
1.12%
(55.10%)
Hold 7|2|12|8|2
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.15
0.16
0.15
0.15
32.87%
21.96%
16.83%
5.13%
Revenuekr M
18.59
18.11
18.30
18.41
(2.19%)
(5.68%)
(3.73%)
(2.02%)
Peers (US$34.74M)
Cap (US$)
PE
34.75M
—
Capital
TTM
5Y
10Y
Leveragex
4.165
(1.206)
(0.951)
EBIT/Intx
0.094
0.130
0.130
Own earn%
(61.11)
(4.17)
1.02
Sh yield%
48.69
25.76
20.67
Owners
Insiders/Inst%
5.70
60.61
Short interest%
2.21
SBC / revenue%
3.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
13–23
$1 testx
—
Incr. ROIC%
20